세계의 HbA1c(헤모글로빈 A1c) 검사 기기 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)

Hemoglobin A1c Testing Devices Market - Scope of Report

TMR's report on the global hemoglobin A1c testing devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global hemoglobin A1c testing devices market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hemoglobin A1c testing devices market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the hemoglobin A1c testing devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global hemoglobin A1c testing devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global hemoglobin A1c testing devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global hemoglobin A1c testing devices market.

The report delves into the competitive landscape of the global hemoglobin A1c testing devices market. Key players operating in the global hemoglobin A1c testing devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global hemoglobin A1c testing devices market profiled in this report.

Key Questions Answered in Global hemoglobin A1c testing devices Market Report:

• What is the sales/revenue generated by hemoglobin A1c testing devices across all regions during the forecast period?
• What are the opportunities in the global hemoglobin A1c testing devices market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Hemoglobin A1c Testing Devices Market - Research Objectives and Research Approach

The comprehensive report on the global hemoglobin A1c testing devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global hemoglobin A1c testing devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global hemoglobin A1c testing devices market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hemoglobin A1c Testing Devices Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, 2020-2034
  • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

• 5.1. PESTEL Analysis
• 5.2. Regulatory Scenario by Region/Country
• 5.3. PORTER's Five Forces Analysis
• 5.4. Product/Brand Analysis of Haemoglobin A1c Testing Devices
• 5.5. Technological Advancement
• 5.6. Incidence and Prevalence Rate of Diabetes

6. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, by Technology

• 6.1. Introduction & Definition
• 6.2. Key Findings/Developments
• 6.3. Market Value Forecast, by Technology, 2020-2034
  • 6.3.1. Cation-exchange Chromatography
  • 6.3.2. Immunoassay
  • 6.3.3. Boronate Affinity Chromatography
  • 6.3.4. Others (Enzymatic assay, etc.)
• 6.4. Market Attractiveness Analysis, by Technology

7. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, by Modality

• 7.1. Introduction & Definition
• 7.2. Key Findings/Developments
• 7.3. Market Value Forecast, by Modality, 2020-2034
  • 7.3.1. Automated
  • 7.3.2. Semi-automated
• 7.4. Market Attractiveness Analysis, by Modality

8. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, by End-user

• 8.1. Introduction & Definition
• 8.2. Key Findings/Developments
• 8.3. Market Value Forecast, by End-user, 2020-2034
  • 8.3.1. Hospitals
  • 8.3.2. Diagnostic Laboratories
  • 8.3.3. Ambulatory Surgical Centres
  • 8.3.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
• 8.4. Market Attractiveness Analysis, by End-user

9. Global Hemoglobin A1c Testing Devices Market Analysis and Forecast, by Region

• 9.1. Key Findings
• 9.2. Market Value Forecast, by Region, 2020-2034
  • 9.2.1. North America
  • 9.2.2. Europe
  • 9.2.3. Asia Pacific
  • 9.2.4. Latin America
  • 9.2.5. Middle East & Africa
• 9.3. Market Attractiveness Analysis, by Region

10. North America Hemoglobin A1c Testing Devices Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast, by Technology, 2020-2034
  • 10.2.1. Cation-exchange Chromatography
  • 10.2.2. Immunoassay
  • 10.2.3. Boronate Affinity Chromatography
  • 10.2.4. Others (Enzymatic assay, etc.)
• 10.3. Market Value Forecast, by Modality, 2020-2034
  • 10.3.1. Automated
  • 10.3.2. Semi-automated
• 10.4. Market Value Forecast, by End-user, 2020-2034
  • 10.4.1. Hospitals
  • 10.4.2. Diagnostic Laboratories
  • 10.4.3. Ambulatory Surgical Centres
  • 10.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
• 10.5. Market Value Forecast, by Country, 2020-2034
  • 10.5.1. U.S.
  • 10.5.2. Canada
• 10.6. Market Attractiveness Analysis
  • 10.6.1. By Technology
  • 10.6.2. By Modality
  • 10.6.3. By End-user
  • 10.6.4. By Country

11. Europe Hemoglobin A1c Testing Devices Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Technology, 2020-2034
  • 11.2.1. Cation-exchange Chromatography
  • 11.2.2. Immunoassay
  • 11.2.3. Boronate Affinity Chromatography
  • 11.2.4. Others (Enzymatic assay, etc.)
• 11.3. Market Value Forecast, by Modality, 2020-2034
  • 11.3.1. Automated
  • 11.3.2. Semi-automated
• 11.4. Market Value Forecast, by End-user, 2020-2034
  • 11.4.1. Hospitals
  • 11.4.2. Diagnostic Laboratories
  • 11.4.3. Ambulatory Surgical Centres
  • 11.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
• 11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
  • 11.5.1. Germany
  • 11.5.2. UK
  • 11.5.3. France
  • 11.5.4. Italy
  • 11.5.5. Spain
  • 11.5.6. Rest of Europe
• 11.6. Market Attractiveness Analysis
  • 11.6.1. By Technology
  • 11.6.2. By Modality
  • 11.6.3. By End-user
  • 11.6.4. By Country/Sub-region

12. Asia Pacific Hemoglobin A1c Testing Devices Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Technology, 2020-2034
  • 12.2.1. Cation-exchange Chromatography
  • 12.2.2. Immunoassay
  • 12.2.3. Boronate Affinity Chromatography
  • 12.2.4. Others (Enzymatic assay, etc.)
• 12.3. Market Value Forecast, by Modality, 2020-2034
  • 12.3.1. Automated
  • 12.3.2. Semi-automated
• 12.4. Market Value Forecast, by End-user, 2020-2034
  • 12.4.1. Hospitals
  • 12.4.2. Diagnostic Laboratories
  • 12.4.3. Ambulatory Surgical Centres
  • 12.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
• 12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
  • 12.5.1. China
  • 12.5.2. Japan
  • 12.5.3. India
  • 12.5.4. Australia & New Zealand
  • 12.5.5. Rest of Asia Pacific
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Technology
  • 12.6.2. By Modality
  • 12.6.3. By End-user
  • 12.6.4. By Country/Sub-region

13. Latin America Hemoglobin A1c Testing Devices Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Technology, 2020-2034
  • 13.2.1. Cation-exchange Chromatography
  • 13.2.2. Immunoassay
  • 13.2.3. Boronate Affinity Chromatography
  • 13.2.4. Others (Enzymatic assay, etc.)
• 13.3. Market Value Forecast, by Modality, 2020-2034
  • 13.3.1. Automated
  • 13.3.2. Semi-automated
• 13.4. Market Value Forecast, by End-user, 2020-2034
  • 13.4.1. Hospitals
  • 13.4.2. Diagnostic Laboratories
  • 13.4.3. Ambulatory Surgical Centres
  • 13.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
• 13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
  • 13.5.1. Brazil
  • 13.5.2. Mexico
  • 13.5.3. Rest of Latin America
• 13.6. Market Attractiveness Analysis
  • 13.6.1. By Technology
  • 13.6.2. By Modality
  • 13.6.3. By End-user
  • 13.6.4. By Country/Sub-region

14. Middle East & Africa Hemoglobin A1c Testing Devices Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast, by Technology, 2020-2034
  • 14.2.1. Cation-exchange Chromatography
  • 14.2.2. Immunoassay
  • 14.2.3. Boronate Affinity Chromatography
  • 14.2.4. Others (Enzymatic assay, etc.)
• 14.3. Market Value Forecast, by Modality, 2020-2034
  • 14.3.1. Automated
  • 14.3.2. Semi-automated
• 14.4. Market Value Forecast, by End-user, 2020-2034
  • 14.4.1. Hospitals
  • 14.4.2. Diagnostic Laboratories
  • 14.4.3. Ambulatory Surgical Centres
  • 14.4.4. Others (Speciality Clinics, Academics & Research Institutes, etc.)
• 14.5. Market Value Forecast, by Country/Sub-region, 2020-2034
  • 14.5.1. GCC Countries
  • 14.5.2. South Africa
  • 14.5.3. Rest of Middle East & Africa
• 14.6. Market Attractiveness Analysis
  • 14.6.1. By Technology
  • 14.6.2. By Modality
  • 14.6.3. By End-user
  • 14.6.4. By Country/Sub-region

15. Competition Landscape

• 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 15.2. Market Share Analysis By Company (2023)
• 15.3. Company Profiles
  • 15.3.1. Alere Technologies AS (Abbott)
    • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.1.2. Product Portfolio
    • 15.3.1.3. Financial Overview
    • 15.3.1.4. SWOT Analysis
    • 15.3.1.5. Strategic Overview
  • 15.3.2. GC Medical Science Corp.
    • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.2.2. Product Portfolio
    • 15.3.2.3. Financial Overview
    • 15.3.2.4. SWOT Analysis
    • 15.3.2.5. Strategic Overview
  • 15.3.3. Osang Healthcare Co., Ltd
    • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.3.2. Product Portfolio
    • 15.3.3.3. Financial Overview
    • 15.3.3.4. SWOT Analysis
    • 15.3.3.5. Strategic Overview
  • 15.3.4. EKF Diagnostics Holdings
    • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.4.2. Product Portfolio
    • 15.3.4.3. Financial Overview
    • 15.3.4.4. SWOT Analysis
    • 15.3.4.5. Strategic Overview
  • 15.3.5. Boditech Med Inc.
    • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.5.2. Product Portfolio
    • 15.3.5.3. Financial Overview
    • 15.3.5.4. SWOT Analysis
    • 15.3.5.5. Strategic Overview
  • 15.3.6. Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
    • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.6.2. Product Portfolio
    • 15.3.6.3. Financial Overview
    • 15.3.6.4. SWOT Analysis
    • 15.3.6.5. Strategic Overview
  • 15.3.7. Eurolyser Diagnostica GmbH
    • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.7.2. Product Portfolio
    • 15.3.7.3. Financial Overview
    • 15.3.7.4. SWOT Analysis
    • 15.3.7.5. Strategic Overview
  • 15.3.8. Bayer AG
    • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.8.2. Product Portfolio
    • 15.3.8.3. Financial Overview
    • 15.3.8.4. SWOT Analysis
    • 15.3.8.5. Strategic Overview
  • 15.3.9. Siemens Healthineers
    • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.9.2. Product Portfolio
    • 15.3.9.3. Financial Overview
    • 15.3.9.4. SWOT Analysis
    • 15.3.9.5. Strategic Overview
  • 15.3.10. Other Prominent Players
    • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 15.3.10.2. Product Portfolio
    • 15.3.10.3. Financial Overview
    • 15.3.10.4. SWOT Analysis
    • 15.3.10.5. Strategic Overview